PEGylated liposomal photosensitizers as theranostic agents for dual-modal photoacoustic and fluorescence imaging-guided photodynamic therapy
The photosensitizer (PS) as photodynamic therapy (PDT) agent, can also serve as the contrast agent for dual-modal fluorescence imaging (FLI) and photoacoustic imaging (PAI) for precise cancer theranostics. In this study, the PAI capability of commercial PS, benzoporphyrin derivative monoacid ring-A...
Main Authors: | Hao Xu, Yubin Liu, Junle Qu, Zhen Yuan |
---|---|
Format: | Article |
Language: | English |
Published: |
World Scientific Publishing
2019-05-01
|
Series: | Journal of Innovative Optical Health Sciences |
Subjects: | |
Online Access: | http://www.worldscientific.com/doi/pdf/10.1142/S1793545819410037 |
Similar Items
-
Liposome Photosensitizer Formulations for Effective Cancer Photodynamic Therapy
by: Sherif Ashraf Fahmy, et al.
Published: (2021-08-01) -
Liposomal photosensitizers: potential platforms for anticancer photodynamic therapy
by: L.A. Muehlmann, et al.
Published: (2011-08-01) -
Liposomal photosensitizers: potential platforms for anticancer photodynamic therapy
by: L.A. Muehlmann, et al.
Published: (2011-08-01) -
Comparison of photoacoustic and fluorescence tomography for the in vivo imaging of ICG-labelled liposomes in the medullary cavity in mice
by: Jana Humbert, et al.
Published: (2020-12-01) -
Measurement of Cyanine Dye Photobleaching in Photosensitizer Cyanine Dye Conjugates Could Help in Optimizing Light Dosimetry for Improved Photodynamic Therapy of Cancer
by: Nadine S. James, et al.
Published: (2018-07-01)